Results 31 to 40 of about 1,183 (178)

Cell-Free DNA Fragmentomics: The New “Omics” on the Block [PDF]

open access: yesClinical Chemistry, 2020
Rossa W K Chiu   +4 more
core   +3 more sources

pyfraglib : An integrated cfDNA fragmentomics platform

open access: yes
Abstract Summary Cell-free DNA (cfDNA) fragmentomics is the analysis of a diverse set of cfDNA fragment features, e.g. fragment length profiles, windowed protection scores, and end motifs. As such it requires software tooling for fragment extraction, statistical feature modeling,
Daniel Schuette   +5 more
openaire   +2 more sources

Liquid biopsy epigenetics: establishing a molecular profile based on cell‐free DNA [PDF]

open access: yesMolecular Oncology
Liquid biopsies containing circulating tumor DNA (ctDNA) are important biomarkers across several forms of cancer. The detection of mutations in cell‐free DNA (cfDNA) indicates the presence of ctDNA.
Christoffer Trier Maansson   +2 more
doaj   +2 more sources

Multidimensional cell-free DNA fragmentomics enables early detection of breast cancer [PDF]

open access: yesBreast Cancer Research
Background Cell-free DNA (cfDNA) fragmentomics represents a transformative approach for early breast cancer detection, offering significant potential to improve patient survival through timely intervention.
Lixian Yang   +9 more
doaj   +2 more sources

GUIDE: a prospective cohort study for blood-based early detection of gastrointestinal cancers using targeted DNA methylation and fragmentomics sequencing

open access: yesMolecular Cancer
Background Gastrointestinal (GI) cancers are among the most prevalent and lethal malignancies worldwide. Early, non-invasive detection is essential for timely intervention and improved survival.
Ao Huang   +28 more
doaj   +2 more sources

A multi-center study for colorectal cancer early detection in high-risk disease patients using cell-free fragmentomics assay

open access: yesCancer Cell International
Background Early detection of colorectal cancer (CRC) is crucial for improving patient survival. This innovative multi-center study aims to develop a non-invasive blood-based assay using cell-free DNA (cfDNA) fragmentomics to differentiate CRC from ...
Bing Gu, Dongqin Zhu, Zejian Lyu
exaly   +2 more sources

A standardized framework for robust fragmentomic feature extraction from cell-free DNA sequencing data [PDF]

open access: yesGenome Biology
Fragmentomics features of cell-free DNA represent promising non-invasive biomarkers for cancer diagnosis. A lack of systematic evaluation of biases in feature quantification hinders the adoption of such applications.
Haichao Wang   +16 more
doaj   +7 more sources

Real‐time analysis of the cancer genome and fragmentome from plasma and urine cell‐free DNA using nanopore sequencing

open access: yesEMBO Molecular Medicine, 2023
Cell‐free DNA (cfDNA) can be isolated and sequenced from blood and/or urine of cancer patients. Conventional short‐read sequencing lacks deployability and speed and can be biased for short cfDNA fragments.
Ymke van der Pol   +16 more
doaj   +1 more source

Cell-Free DNA Fragmentation Patterns in a Cancer Cell Line

open access: yesDiagnostics, 2022
Unique bits of genetic, biological and pathological information occur in differently sized cell-free DNA (cfDNA) populations. This is a significant discovery, but much of the phenomenon remains to be explored. We investigated cfDNA fragmentation patterns
Vida Ungerer   +3 more
doaj   +1 more source

At the dawn: cell-free DNA fragmentomics and gene regulation [PDF]

open access: yesBritish Journal of Cancer, 2021
AbstractEpigenetic mechanisms play instrumental roles in gene regulation during embryonic development and disease progression. However, it is challenging to non-invasively monitor the dynamics of epigenomes and related gene regulation at inaccessible human tissues, such as tumours, fetuses and transplanted organs.
openaire   +2 more sources

Home - About - Disclaimer - Privacy